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The first sympathectomy was performed by Alexander in
1889 to treat epilepsy. Over the years, this procedure has
been used by countless doctors to treat conditions such as
exophthalmos, ischemic lesions due to arterial obstructions,
scleroderma, epigastric paralysis, among others (1).
The surgical approach involves resection of the cervical
ganglia, inevitably resulting in Horner’s Syndrome, which is
a combination of signs and symptoms caused by the rupture
of a nerve pathway from the brain to the face and eyes,
affecting the side of the surgery (2).
In 1916, Thomas Jonnesco performed the first left cardiac
sympathetic denervation in a patient with uncontrollable
angina and ventricular tachycardia (3). The first endoscopic
sympathectomy was performed by Hughes in 1942; how-
ever, it was only in the following decade that Kux (4)
published his experience with the technique (1). In the 1990s,
with the advancement and incorporation of new technol-
ogies, video-assisted thoracic sympathectomy became a routine
practice, and primary or essential hyperhidrosis became the
main indication for thoracic sympathectomy (5).
In video-assisted thoracic sympathectomy, the patient under-
goes general anesthesia in a semi-seated position at 45o. The
harmonic or electric scalpel and the video camera are inserted
through one or two incisions measuring less than one cen-
timeter, and then the sympathetic chain is sectioned at the
appropriate levels (6).
The endoscopic approach provides numerous advan-
tages such as reduced postoperative pain, a shorter hospital
stay, earlier return to normal activities, and better aesthetic
results (7,8).
In cardiology, thoracic sympathectomy has been indicated
to treat patients with severe angina pectoris, long QT
syndrome (9), and catecholaminergic ventricular tachycardia
(10) in selected cases. The most significant effects on cardiac
sympathetic activity seem to be related to the excision or
blockage of the left stellate ganglion and the subsequent
sympathetic chain (11).
A study tested sympathectomy by clipping the lower third
of the left stellate ganglion and T3-T4 thoracic nerves using
videothoracoscopy in ten patients with class II and III heart
failure. The results of this group were compared with those
of five patients undergoing clinical treatment in the con-
trol group. The results suggest a difference between the two
groups regarding improvement in the functional class. The
patients undergoing sympathectomy showed a statistically
significant improvement in the six-minute walk test and the
quality of life questionnaire (12,13).
In patients with cardiac arrhythmia, sympathectomy has
been described as a measure to mitigate tachycardia that is
refractory to clinical treatment and ablation, especially in
cases of channelopathies (14,15).
Another multicenter study evaluated the role of sym-
pathetic cardiac denervation in implantable cardioverter-
defibrillator (ICD) patients with structural heart disease and
recurrent ventricular tachyarrhythmias after one year. About
a third of the patients stopped taking antiarrhythmic drugs
with 50% ICD shock-free survival (16).
Sympathetic denervation has been consolidated as a
therapeutic option for patients with long QT syndrome in
whom drug therapy has already been optimized, and the
application of inappropriate cardioverter-defibrillator shocks
compromises the quality of life. The effectiveness of sym-
pathectomy was studied in 85 symptomatic patients who
had long QT syndrome for six years, with a 45% decrease in
cardiac events and an 8% decrease in sudden death (17).
Another study followed up patients who underwent
sympathectomy for eight years. Approximately 99% of the
patients were symptomatic in the preoperative period, with
48% presenting with aborted cardiorespiratory arrest and
75% presenting with recurrent syncope even with the maxi-
mum dose of beta-blockers. After sympathectomy, 46% of
patients remained asymptomatic, and there was a 91%
decrease in cardiac events and a significant decrease in the
length of the QT interval (9).
Thoracic sympathectomy may also be indicated for the
treatment of angina in some cases, which was suggested by
Franc¸ois Franck based on his studies and understanding of
the afferent sympathetic pathways (18).
A T2-T4 sympathetic block causes vasodilation, which can
be a useful tool for selected cases of angina refractory to
conventional treatment. However, this intervention should
be indicated with caution due to hemodynamic instability
that can occur if the origin of the angina is not treated (19).
Some cases in the literature describe the effectiveness of
sympathectomy in pediatric patients with congenital heart
disease and ventricular tachyarrhythmia refractory to surgi-
cal treatment (20).
There is a place for surgical sympathectomy in cardiology,
which should be considered a therapeutic option for patients
with heart failure, long QT syndrome, and catecholaminergic
ventricular tachycardia resistant to conventional treatment.
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ICD is the main approach for patients with ventricular
arrhythmias.
Currently, the initial phase of a study on whether sym-
pathectomy inhibits the triggering mechanisms of ventricular
arrhythmia and reduces the amount of ICD shocks in
patients with Chagas cardiomyopathy and recurrent sus-
tained monomorphic ventricular tachycardia has presented
very encouraging results.
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